Patients with the hospital and ambulance, diagnosed disorder of the exploit of hemp – defined as the inability to stop the exploit of marijuana, even when the drug causes damage – He died almost three times more than people without disturbance in the next five years, according to the study published on Thursday, the largest on this subject.
Patients with disorder of the exploit of cannabis were 10 times more likely that he would die through suicide than in patients in the general population. They often die of trauma, drug poisoning and lung cancer. These numbers suggest that the disorder of the exploit of cannabis is about half as hazardous as opioid addiction and slightly less hazardous than alcohol consumption, the scientists say.
The second report, published on Tuesday, showed that more schizophrenia and psychosis in Canada have been associated since the drug has been legalized.
“Many people think:” Oh, marijuana is not harmful – it is organic, it’s natural; How great, “said Dr. Laura Bierut, psychiatrist from Washington University School of Medicine in St. Louis, who is the author editorial accompanying the risk of death risk. But marijuana sold today is much stronger and more harmful than what they burned the boom in the 1960s and 1970s.
“It’s a threat to public health, just like alcohol,” said Dr. Bierut.
Recent studies suggest this three out of 10 cannabis users I develop a disorder of the exploit of cannabis, defined as unable to stop using marijuana, although it causes stern health and social problems. As in the case of alcohol, many people exploit marijuana recreationally without side effects or addiction.
Scientists took advantage of registers in Ontario, which capture millions of inhabitants with a government healthcare system, which includes 97 percent of the population.
Based on the provisions, scientists in the Thursday study identified 106,994 people who were diagnosed with hemp exploit during a visit to the emergency department or hospitalization in 2006–2021.
Scientists associated entries with essential records of statistics and found that 3.5 percent of them died during five years of treatment of disorder. In a matching comparative group of people of the same age and sex, the mortality rate was 0.6 percent.
Then the authors made corrections to take into account other risk factors that could contribute to their death, including mental health disorders, other exploit of substances and conditions such as heart disease and cancer.
Even when they died for these other reasons, scientists came to the conclusion that patients with disorder of the exploit of cannabis had a 2.8-fold risk of death compared to the general population. The risk was the highest in adolescent adults aged 25 to 44.
Dr. Daniel Myran, assistant to a family medicine professor at the University of Ottawa and the first author of the study, noted that they are most likely underestimating cannabis fees.
“It is estimated that for each person treated for a miracle there is another three who did not seek care,” he said. “So it’s not just a miracle, but it’s bad enough that they were looking for it.”
He also noticed that the study could not clearly determine whether marijuana herself increased the risk of death, or another lifestyle or health factors that are more common among hefty cannabis users.
“Anyway, this group is really, very high risk and can take advantage of intervention, monitoring and prevention,” he said.
On Tuesday, the same research group published a study in which the last legalization of marijuana in Canada Psychosis and schizophrenia indicators.
The exploit of cannabis is associated with the development of schizophrenia, a stern mental illness, as well as momentary psychotic episodes characterized by loss of contact with reality. Some studies have not shown a relationship between the legalization of marijuana and the boost in these disorders, but many studies are too diminutive to detect changes in the dissemination of psychotic disorders that are infrequent.
The modern study analyzed psychosis associated with Indian cannabis in Canada in three periods: before the country created a legal mariuis (2006–2015), among the expansion of the exploit of medical and non-medical hemp (2015-2018) and after recreational exploit of cannabis (2018-2022) .
Schizophrenia indicators were stable over time. However, the percentage of cases attributed to the disorder of the exploit of cannabis increased to 10.3 percent during the legalization period, compared to 3.7 percent before legalization, the authors found. The psychosis indicator (without the diagnosis of schizophrenia) almost doubled after legalization.
Jodi Gilman, a professor of psychiatry at Harvard Medical School, adolescent adults aged 19 to 24, were the most vulnerable Comment on the research.
“This is a period of life in which the brain is still developing and still susceptible to the effects of marijuana,” said Dr. Gilman. Psychosis and schizophrenia are also known for developing adult at a adolescent age, she added: “So you have a double hit.”